Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
C15orf55
REST API REST API
Homo sapiens
C15orf55 is differentially expressed in 91 experiments: 43 organism parts: mammary gland, testis, ... (41 more);, 34 disease states: normal, breast carcinoma, ... (32 more);, 42 cell types 30 cell lines 9 compound treatments and 39 other conditions.
Synonyms NUT, DKFZp434O192
Orthologs C15orf55 (Bos taurus)   BC125332 (Mus musculus)   Nut (Rattus norvegicus)   C15orf55 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term cytoplasm, nucleus
UniProt Accession Q86Y26, C9JN79, E7EVE8, F5H4I6
Search EB-eye ENSG00000184507
Show more properties
Experimental Factors
Organism part

studied in E-MTAB-37, E-AFMX-5, E-GEOD-6573, E-GEOD-18105, E-AFMX-6, ... (10 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-MTAB-37, E-GEOD-5823, E-MEXP-2034, E-GEOD-20089, E-GEOD-19639, ... (11 experiments)

Factor Value U/D Experiments
MCF-7
2
E-GEOD-20081, E-GEOD-5823
NCIH2009
1
E-MTAB-37
SW756
1
E-MTAB-37
U-937
1
E-GEOD-24147
CCRFCEM
2
1
E-GEOD-24147
NCIH2405
1
E-MTAB-37
24 more value(s).


Cell type

studied in E-GEOD-18811, E-AFMX-5, E-GEOD-22373, E-GEOD-20033, E-TABM-130, ... (19 experiments)

Factor Value U/D Experiments
promyelocyte
1
E-GEOD-12662
LCC
1
1
E-GEOD-19188
hematopoietic stem cell
1
E-MEXP-1403
adipocyte
1
E-AFMX-5
spermatid
1
E-TABM-130
macrophage
1
E-GEOD-22373
36 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-19743, E-GEOD-6872, E-GEOD-15960, E-MEXP-2442, ... (19 experiments)

Factor Value U/D Experiments
breast carcinoma
3
E-TABM-276, E-MTAB-37, E-GEOD-7307
extranodal NK/T-cell lymphoma
1
E-TABM-702
anaplastic large cell lymphoma
1
E-GEOD-6338
NDV
1
1
E-GEOD-18791
control
1
E-GEOD-8121
septic shock
1
E-GEOD-8121
28 more value(s).


Compound treatment

studied in E-GEOD-7400, E-GEOD-3284, E-MEXP-2241, E-GEOD-20081

Factor Value U/D Experiments
4-hydroxytamoxifen
2
1
E-MEXP-2241
ethanol
3
1
E-MEXP-2241
no estradiol
1
E-GEOD-20081
control
10
1
E-GEOD-3284
granulocyte-colony stimulating factor
1
E-GEOD-7400
none
1
E-GEOD-7400
3 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
tunicamycin
1
E-GEOD-19519
DMSO
1
1
E-GEOD-19519
thapsigargin
1
E-GEOD-19519


Biosource provider
studied in E-MTAB-37, E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-GEOD-19420, E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, ... (7 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-21589, E-GEOD-16363

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-21138

Environmental stress
studied in E-GEOD-1643

Estrogen receptor status
studied in E-GEOD-6532

family id
studied in E-GEOD-19519

Genotype
studied in E-GEOD-17476, E-MEXP-1403

Gestation age
studied in E-GEOD-14334

Growth condition
studied in E-GEOD-20540

Histology
studied in E-TABM-234, E-GEOD-21653, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-GEOD-19330, E-TABM-666, E-GEOD-19519, ... (13 experiments)

Infection
studied in E-GEOD-12108, E-MEXP-561

Injury
studied in E-GEOD-19743

Ki67 ihc
studied in E-GEOD-21653

Material type
studied in E-GEOD-9171

Metastasis
studied in E-GEOD-18105

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

Population
studied in E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-19445, E-GEOD-19246

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

Sampling time point
studied in E-GEOD-19743

Sex
studied in E-GEOD-7307

Stimulation
studied in E-GEOD-20114

stimulus
studied in E-GEOD-22103

Survival time
studied in E-GEOD-19188

Test result
studied in E-TABM-276

Treatment
studied in E-GEOD-16837, E-GEOD-19246

Tumor grading
studied in E-GEOD-4271

Processing time: 0.46 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM